Investor
Xoma Royalty
Emeryville · United States
A biotech royalty aggregator acquiring economic rights to future milestone and royalty payments associated with partnered pre-commercial clinical candidates.
Stage
Not confirmed
Sectors
Digital Health
Cheque
Not confirmed
Invests in
Global
Sectors
About
This biotech royalty aggregator acquires economic rights to potential milestone and royalty payments associated with pre-commercial clinical candidates and commercial therapies. The firm provides non-dilutive, non-recourse funding to help biotech companies advance internal drug candidates. It focuses on development-stage assets with blockbuster potential licensed to well-capitalized partners. By building a portfolio of rights across multiple therapeutic indications, the firm mitigates single-asset binary risk for its investors.
How to approach
Contact the business development team if you hold royalty licenses to pre-commercial therapeutic assets in active development.
Portfolio · 5 · tap a company to read about it